DK1133559T3 - Human-G-protein-koblet orphan receptor RUP3 - Google Patents

Human-G-protein-koblet orphan receptor RUP3

Info

Publication number
DK1133559T3
DK1133559T3 DK99972682T DK99972682T DK1133559T3 DK 1133559 T3 DK1133559 T3 DK 1133559T3 DK 99972682 T DK99972682 T DK 99972682T DK 99972682 T DK99972682 T DK 99972682T DK 1133559 T3 DK1133559 T3 DK 1133559T3
Authority
DK
Denmark
Prior art keywords
protein
human
rup3
orphan receptor
coupled orphan
Prior art date
Application number
DK99972682T
Other languages
Danish (da)
English (en)
Inventor
James N Leonard
Ruoping Chen
Original Assignee
Arena Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharm Inc filed Critical Arena Pharm Inc
Application granted granted Critical
Publication of DK1133559T3 publication Critical patent/DK1133559T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99972682T 1998-11-20 1999-10-13 Human-G-protein-koblet orphan receptor RUP3 DK1133559T3 (da)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US10921398P 1998-11-20 1998-11-20
US12041699P 1999-02-16 1999-02-16
US12185299P 1999-02-26 1999-02-26
US12394699P 1999-03-12 1999-03-12
US12394999P 1999-03-12 1999-03-12
US13713199P 1999-05-28 1999-05-28
US13712799P 1999-05-28 1999-05-28
US13643799P 1999-05-28 1999-05-28
US13643999P 1999-05-28 1999-05-28
US13643699P 1999-05-28 1999-05-28
US13656799P 1999-05-28 1999-05-28
US14144899P 1999-06-29 1999-06-29
US15663499P 1999-09-29 1999-09-29
US15663399P 1999-09-29 1999-09-29
US15665399P 1999-09-29 1999-09-29
US15655599P 1999-09-29 1999-09-29
US15728199P 1999-10-01 1999-10-01
US15728299P 1999-10-01 1999-10-01
US15728099P 1999-10-01 1999-10-01
US15729399P 1999-10-01 1999-10-01
US15729499P 1999-10-01 1999-10-01
US41676099A 1999-10-12 1999-10-12
US41704499A 1999-10-12 1999-10-12

Publications (1)

Publication Number Publication Date
DK1133559T3 true DK1133559T3 (da) 2006-04-10

Family

ID=27586698

Family Applications (3)

Application Number Title Priority Date Filing Date
DK99972682T DK1133559T3 (da) 1998-11-20 1999-10-13 Human-G-protein-koblet orphan receptor RUP3
DK05003040T DK1584683T3 (da) 1998-11-20 1999-10-13 Human G-protein-koblet orphan receptor RUP3
DK07008841T DK1849866T3 (da) 1998-11-20 1999-10-13 Human orphan G-protein-koblet receptor RUP3

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK05003040T DK1584683T3 (da) 1998-11-20 1999-10-13 Human G-protein-koblet orphan receptor RUP3
DK07008841T DK1849866T3 (da) 1998-11-20 1999-10-13 Human orphan G-protein-koblet receptor RUP3

Country Status (12)

Country Link
EP (8) EP1580271A3 (fr)
JP (5) JP2003534767A (fr)
KR (5) KR100926208B1 (fr)
AT (3) ATE301673T1 (fr)
AU (2) AU770056B2 (fr)
CA (2) CA2645717A1 (fr)
DK (3) DK1133559T3 (fr)
ES (3) ES2289610T3 (fr)
IL (2) IL142538A0 (fr)
NZ (3) NZ527622A (fr)
PT (3) PT1133559E (fr)
WO (1) WO2000031258A2 (fr)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1690939B8 (fr) 1998-03-12 2010-10-13 Astellas Pharma Inc. Nouvelles protéines du récepteur couplé à la protéine G
US6071722A (en) * 1998-04-24 2000-06-06 Smithkline Beecham Corporation Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
JP2002512780A (ja) * 1998-04-24 2002-05-08 スミスクライン ビーチャム コーポレーション 新規７ｔｍ受容体ａｘｏｒ−２のクローニング
WO2000026339A2 (fr) * 1998-11-03 2000-05-11 Smithkline Beecham Corporation Recepteur couple aux proteines g, dit axor-14
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
EP1157038A4 (fr) * 1999-02-26 2005-01-19 Smithkline Beecham Corp Clonage du recepteur 7tm (axor 17) du type p2y
US6620615B1 (en) * 1999-04-23 2003-09-16 Curagen Corporation G-protein coupled receptor—encoding nucleic acids
EP1189944A4 (fr) * 1999-06-21 2002-09-11 Smithkline Beecham Corp Axor16, r cepteur coupl une prot ine g
JP2003504054A (ja) * 1999-07-13 2003-02-04 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Ｇ−タンパク質共役型受容体およびそのｄｎａ配列
CA2381437A1 (fr) * 1999-07-30 2001-02-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Recepteur couple g-proteine et sequences adn de celui-ci
CA2382889A1 (fr) * 1999-08-27 2001-03-08 Takuya Watanabe Nouvelle proteine receptrice couplee a une proteine g, et son adn
US6998255B1 (en) 1999-09-24 2006-02-14 Solvay Pharmaceuticals B.V. Human G-protein coupled receptor
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
US6204017B1 (en) 1999-10-07 2001-03-20 Schering Corporation Polynucleotide encoding a histamine receptor
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9923893D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9924960D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
GB9924956D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
AU1575601A (en) * 1999-10-27 2001-05-08 Pharmacia & Upjohn Company G protein-coupled receptors expressed in brain
ATE375390T1 (de) * 1999-10-29 2007-10-15 Pfizer G-protein-gekoppelter rezeptor-ähnliche proteine
WO2001032864A2 (fr) * 1999-11-03 2001-05-10 Merck Patent Gmbh Nouveaux polypeptides de type gpcr_kd5 et sequences d'adn correspondantes
US6461836B1 (en) * 1999-11-05 2002-10-08 Smithkline Beecham Corporation Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
US7029857B1 (en) 1999-12-17 2006-04-18 H. Lundbeck A/S Processes for obtaining compounds employing SNORF72 receptors
WO2001046414A1 (fr) * 1999-12-20 2001-06-28 Banyu Pharmaceutical Co., Ltd. Nouvelle proteine receptrice couplee a la proteine de fixation de guanosine triphosphate, bg26
AU2288601A (en) 1999-12-23 2001-07-03 Millennium Pharmaceuticals, Inc. P2Y12 receptor
AU2230401A (en) * 1999-12-28 2001-07-09 Helix Research Institute Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same
GB0001700D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Novel protein
DE60129933T2 (de) 2000-02-04 2008-02-14 Takeda Pharmaceutical Co. Ltd. Verfahren zum screening
EP1266005B1 (fr) * 2000-03-14 2007-03-07 Bayer HealthCare AG Regulation de la proteine de type du recepteur de la lipoxine a4 humaine
WO2001068844A2 (fr) * 2000-03-17 2001-09-20 Bayer Aktiengesellschaft Regulation du recepteur humain du leucotriene de type b4, couple a la proteine g
US20030077709A1 (en) * 2000-03-21 2003-04-24 Masazumi Kamohara Novel leukotriene B4 receptor
AU2001242800A1 (en) * 2000-03-28 2001-10-08 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
WO2001073023A1 (fr) * 2000-03-31 2001-10-04 Helix Research Institute Nouveau recepteur gprv53 couple a une proteine se liant a la guanosine-triphosphate, gene correspondant et procede de production et d'utilisation associe
WO2001077326A1 (fr) * 2000-04-12 2001-10-18 Takeda Chemical Industries, Ltd. Proteine receptrice couplee a la proteine g et son adn
EP1178110A1 (fr) * 2000-08-01 2002-02-06 Aventis Pharma Deutschland GmbH Récepteur EDG8 de la sphingosine 1-phosphate , sa préparation et son utilisation
EP1287133B1 (fr) * 2000-05-18 2006-12-13 Bayer HealthCare AG Regulation de recepteur couple aux proteines g de type dopamine humain
WO2002000719A2 (fr) * 2000-06-23 2002-01-03 Tularik Inc. Nouveaux recepteurs
WO2002000725A2 (fr) * 2000-06-26 2002-01-03 Akzo Nobel N.V. Org10, recepteur couple a une proteine g
WO2002002599A2 (fr) * 2000-06-30 2002-01-10 Ingenium Pharmaceuticals Ag Recepteur couple aux proteines g humaines igpcr17, et son utilisation
AU2001271838A1 (en) 2000-07-06 2002-01-21 Bayer Corporation Human neuropeptide y-like g protein-coupled receptor
EP1311546A2 (fr) * 2000-08-09 2003-05-21 Millenium Pharmaceuticals, Inc. Methodes d'utilisation d'un recepteur (14266) couple aux proteines g humaines
US6790608B2 (en) 2000-09-20 2004-09-14 The Regents Of The University Of California Methods of identifying and ADP-glucose receptor ligand, agonist or antagonist
AU2002210982A1 (en) 2000-11-01 2002-05-15 Yamanouchi Pharmaceutical Co..Ltd. Method of screening antiplatelet
JP4178028B2 (ja) * 2000-11-07 2008-11-12 タケダ ケンブリッジ リミテッド 受容体
AU1989002A (en) * 2000-11-27 2002-06-03 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
EP1338651B9 (fr) 2000-12-01 2007-05-09 Astellas Pharma Inc. Procede de depistage d'un remede
AU2002246680A1 (en) 2000-12-22 2002-07-30 University Of South Florida Sphingosine 1-phosphate receptor gene, sppr
WO2002052047A2 (fr) * 2000-12-22 2002-07-04 Mergen Ltd. Procedes concernant l'identification de recepteurs couples a la proteine g associes a des maladies
GB0100782D0 (en) * 2001-01-11 2001-02-21 Glaxo Group Ltd Assay
ES2311601T3 (es) * 2001-04-25 2009-02-16 Astellas Pharma Inc. Receptores acoplado a proteina que se une a trifosfato de guanosina place 6002312 y su gen y produccion y uso del mismo.
US7858755B2 (en) 2001-07-09 2010-12-28 Euroscreen S.A. Monoclonal antibodies that bind Chemerin polypeptide
US7419658B2 (en) 2001-07-09 2008-09-02 Euroscreen S.A. Isolated ligand of ChemerinR
US20030096299A1 (en) 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
US6946244B2 (en) 2001-08-07 2005-09-20 Euroscreen, S.A. Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)
CN1324047C (zh) 2002-04-12 2007-07-04 先灵公司 G蛋白偶联受体的配体与方法
AU2003261874A1 (en) * 2002-09-02 2004-03-29 Takeda Pharmaceutical Company Limited Adrenocortical hormone secretion controller
JPWO2004033687A1 (ja) * 2002-10-11 2006-02-09 アステラス製薬株式会社 腎不全治療薬をスクリーニングする方法
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
JP4516430B2 (ja) 2002-12-20 2010-08-04 メルク・シャープ・エンド・ドーム・コーポレイション １−（アミノ）インダン並びに（１，２−ジヒドロ−３−アミノ）−ベンゾフラン、ベンゾチオフェン及びインドール
CA2512899A1 (fr) 2003-01-14 2004-08-05 Arena Pharmaceuticals Inc. Derives aryles et heteroaryles tri-substitues en position 1,2,3 en tant que modulateurs de metabolisme et prophylaxie et traitement de troubles lies au metabolisme
US7083933B1 (en) 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
US7524638B1 (en) 2003-06-27 2009-04-28 Osi Pharmaceuticals, Inc. Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
CN1812803A (zh) * 2003-06-27 2006-08-02 唐纳士公司 人类肥大细胞表达的膜蛋白
DOP2006000008A (es) * 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
GB0508990D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
EP1971862B1 (fr) 2006-04-11 2010-11-10 Arena Pharmaceuticals, Inc. Procédés d'utilisation du récepteur gpr119 pour identifier des composés utiles pour augmenter la masse osseuse chez un individu
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
BRPI0814294A2 (pt) 2007-07-19 2015-02-03 Metabolex Inc Agonistas de receptor heterocíclico ligado a n para o tratamento do diabetes e de desordens metabólicas.
JP5465177B2 (ja) 2007-09-20 2014-04-09 アイアールエム・リミテッド・ライアビリティ・カンパニー Ｇｐｒ１１９活性のモジュレーターとしての化合物および組成物
EP2108960A1 (fr) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Procédés d'utilisation d'un récepteur couplé à protéine G pour identifier les secrétagogues de peptide YY (PYY) et composés utiles dans le traitement des conditions modulées de secrétagogues BY (PYY) et composés utiles dans le traitement des conditions par PYY
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
US8410127B2 (en) 2009-10-01 2013-04-02 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
JP2013523819A (ja) 2010-04-06 2013-06-17 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｇｐｒ１１９レセプターのモジュレーターおよびそれに関連する障害の処置
BR112012032248A2 (pt) 2010-06-23 2016-09-13 Metabolex Inc composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
CN103539791B (zh) 2010-09-22 2017-01-11 艾尼纳制药公司 Gpr119 受体调节剂和对与其相关的障碍的治疗
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145361A1 (fr) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
WO2012145604A1 (fr) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
WO2012145603A1 (fr) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
WO2012170702A1 (fr) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci
WO2013055910A1 (fr) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles associés
WO2014074668A1 (fr) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulateurs de gpr119 et traitement de troubles associés à ceux-ci
CA3002540C (fr) 2015-01-06 2023-11-07 Arena Pharmaceuticals, Inc. Utilisation de (r)-2-(7-(4-cyclopentyl-3(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acide acetique pour le traitement de conditions liees au recepteur s1p1
WO2016209809A1 (fr) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique (composé 1) pour une utilisation dans des troubles associés au récepteur de s1p1
AU2017305392A1 (en) 2016-08-03 2019-02-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
MA49456A (fr) 2017-06-19 2020-04-29 Arena Pharm Inc Composés et procédés pour le traitement de nafld et de nash
ES2987794T3 (es) 2018-06-06 2024-11-18 Arena Pharm Inc Procedimientos de tratamiento de afecciones relacionadas con el receptor S1P1

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2237937A1 (fr) * 1995-11-15 1997-06-05 Cor Therapeutics, Inc. Nouveau recepteur purinergique
WO1997024929A1 (fr) * 1996-01-11 1997-07-17 Human Genome Sciences, Inc. Recepteur couple de la proteine g humaine
WO1998031810A2 (fr) * 1997-01-21 1998-07-23 Schering Corporation Chemokines de mammiferes, recepteurs, reactifs, utilisations
US6221627B1 (en) * 1997-02-24 2001-04-24 Smithkline Beecham Corporation cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor
US5955303A (en) * 1997-03-06 1999-09-21 Incyte Pharmaceuticals, Inc. Human chemokine receptor-like protein
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US6060272A (en) * 1997-05-07 2000-05-09 Human Genome Sciences, Inc. Human G-protein coupled receptors
EP0899332A3 (fr) * 1997-08-15 2000-07-05 Smithkline Beecham Corporation HFIAO41, un récepteur couplé à la protéine G
CA2239255A1 (fr) * 1997-10-23 1999-04-23 Smithkline Beecham Corporation Clone adnc hneaa81 codant pour un recepteur transmembranaire humain a 7 domaines
US5932445A (en) * 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins
KR100629185B1 (ko) * 1997-11-11 2006-09-28 오노 야꾸힝 고교 가부시키가이샤 인간 리조포스파티드산 수용체 물질 및 그 용도
US6207412B1 (en) * 1997-11-13 2001-03-27 The Regents Of The University Of California Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
EP1054903A4 (fr) * 1998-02-20 2002-10-09 Smithkline Beecham Corp Fishboy, un recepteur couple a la proteine g
EP1690939B8 (fr) * 1998-03-12 2010-10-13 Astellas Pharma Inc. Nouvelles protéines du récepteur couplé à la protéine G
AU3749499A (en) * 1998-04-16 1999-11-01 Millenium Pharmaceuticals, Inc. Novel molecules of the bgckr-related protein family and uses thereof
JP2002512780A (ja) * 1998-04-24 2002-05-08 スミスクライン ビーチャム コーポレーション 新規７ｔｍ受容体ａｘｏｒ−２のクローニング
SE9801455D0 (sv) * 1998-04-24 1998-04-24 Astra Pharma Inc New receptor
US6071722A (en) * 1998-04-24 2000-06-06 Smithkline Beecham Corporation Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
JP2002531057A (ja) * 1998-08-19 2002-09-24 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Ｅｄｇ受容体ファミリーに関連したｇタンパク質結合受容体である１４２７４受容体
EP1104465A1 (fr) * 1998-08-20 2001-06-06 Millennium Pharmaceuticals, Inc. Recepteur couple a la proteine g, dit recepteur 14400
WO2000011015A1 (fr) * 1998-08-24 2000-03-02 Alphagene, Inc. Proteines secretees et polynucleotides codant pour ces proteines
WO2000012707A1 (fr) * 1998-09-02 2000-03-09 Millennium Pharmaceuticals, Inc. Recepteur 14926, nouveau recepteur couple a la proteine g
NZ510712A (en) * 1998-10-13 2004-11-26 Arena Pharm Inc Non-endogenous, constitutively activated human G protein-coupled receptors
WO2000023588A2 (fr) * 1998-10-16 2000-04-27 Millennium Pharmaceuticals, Inc. Recepteurs couples a la proteine g
EP1127128A1 (fr) * 1998-11-04 2001-08-29 Chiron Corporation Polypeptides isoles du recepteur vshk-1 et leurs techniques d'utilisation
DE69933688T2 (de) * 1998-11-06 2007-08-23 Bayer Healthcare Ag G-protein-gekoppelter rezeptoren, die holomog zu ebv-induzierter gpcr (ebi-2) sind, verfahren zur identifizierung von ihren entsprechenden liganden
US6221660B1 (en) * 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
US6689866B1 (en) * 1999-03-09 2004-02-10 Curagen Corporation Polynucleotides and proteins encoded thereby
US6590938B1 (en) * 1999-09-30 2003-07-08 Conexant Systems, Inc. DCT domain conversion of a higher definition signal to lower definition signal
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide

Also Published As

Publication number Publication date
AU770056B2 (en) 2004-02-12
AU3790400A (en) 2000-06-13
EP1849866A3 (fr) 2007-11-07
NZ511087A (en) 2004-01-30
DK1584683T3 (da) 2007-10-29
KR100963367B1 (ko) 2010-06-14
EP1849866B1 (fr) 2008-05-21
EP2295572A1 (fr) 2011-03-16
EP1780280A1 (fr) 2007-05-02
JP2007209352A (ja) 2007-08-23
ATE366815T1 (de) 2007-08-15
KR20070097564A (ko) 2007-10-04
ATE301673T1 (de) 2005-08-15
EP1133559B1 (fr) 2005-08-10
KR20010086040A (ko) 2001-09-07
EP1849866A2 (fr) 2007-10-31
WO2000031258A3 (fr) 2000-10-05
JP2008133300A (ja) 2008-06-12
AU2004202147A1 (en) 2004-06-10
KR20080024234A (ko) 2008-03-17
ES2243095T3 (es) 2005-11-16
ES2289610T3 (es) 2008-02-01
HK1103763A1 (en) 2007-12-28
PT1584683E (pt) 2007-10-17
EP1580271A2 (fr) 2005-09-28
ATE396400T1 (de) 2008-06-15
EP1580271A3 (fr) 2006-01-18
DK1849866T3 (da) 2008-09-08
KR20080104062A (ko) 2008-11-28
CA2348377C (fr) 2008-12-02
NZ527622A (en) 2005-03-24
JP2009298791A (ja) 2009-12-24
KR100926209B1 (ko) 2009-11-09
CA2348377A1 (fr) 2000-06-02
KR100926208B1 (ko) 2009-11-09
PT1849866E (pt) 2008-08-28
EP2295574A1 (fr) 2011-03-16
IL142538A0 (en) 2002-03-10
WO2000031258A2 (fr) 2000-06-02
EP1584683A1 (fr) 2005-10-12
CA2645717A1 (fr) 2000-06-02
KR100765039B1 (ko) 2007-10-09
EP2295573A1 (fr) 2011-03-16
JP2003534767A (ja) 2003-11-25
JP2004267216A (ja) 2004-09-30
EP1133559A2 (fr) 2001-09-19
PT1133559E (pt) 2005-10-31
NZ537625A (en) 2006-08-31
IL142538A (en) 2010-11-30
ES2308759T3 (es) 2008-12-01
KR20080024233A (ko) 2008-03-17
HK1037675A1 (en) 2002-02-15
EP1584683B1 (fr) 2007-07-11

Similar Documents

Publication Publication Date Title
DK1133559T3 (da) Human-G-protein-koblet orphan receptor RUP3
DE69837606D1 (de) Cystein-reiche rezeptoren-train
AUPO755097A0 (en) Receptor agonist and antagonist
PT1421115E (pt) Receptor de celulas t soluvel
ATE400558T1 (de) Metabotropische glutamatrezeptor-antagonisten
DK1047781T3 (da) IL-18-receptorer
DE69709561D1 (de) Östrogen-Rezeptor
SMP200600024B (it) 2,6-Biseteroaril-4-amminopirimidine come antagonisti del recettore dell'adenosina
MA26878A1 (fr) Regulateurs de recepteurs d'adenosine
DE60025241D1 (de) HäMOPOIETINREZEPTOR-PROTEIN, NR12
AUPR833401A0 (en) G protein-coupled receptor antagonists
WO2002068600A3 (fr) Versions endogene et non endogenes de recepteurs humains couples aux proteines g
ATE432282T1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
IS6761A (is) Estrógen viðtakastillar
ES2147167T1 (es) Procedimiento de identificacion de moduladores de receptores de membrana de superficie celular util para el tratamiento de enfermedades.
DE50008020D1 (de) Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten
WO2002042461A3 (fr) Versions endogene et non endogene de recepteurs couples aux proteines g humaines
DE60130000D1 (de) Zwitterionische tachykinin-rezeptor-antagonisten
ATE464893T1 (de) N,n'-diarylguanidine als il-8-rezeptor- antagonisten
WO2000050563A3 (fr) Recepteur couple a une proteine g ressemblant aux recepteurs de galanine
SE9702794D0 (sv) New compounds
PT1042320E (pt) Novos compostos que sao antagonistas de receptores duplos de ourinoceptores p2 e de proteina g 7-transmembranar
CY1107740T1 (el) Ανθρωπινος ορφανος συζευγμενος σε g πρωτεϊνη υποδοχεας rup3
EP0943685A3 (fr) Récepteur couplé à la protein G provenant du cerveau human
NO20035670L (no) En ny G-proteinkoplet reseptor, GAVE 3